• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用比较分子力场分析绘制小肠肽转运体(PepT1)的结合位点图谱。

Mapping the binding site of the small intestinal peptide carrier (PepT1) using comparative molecular field analysis.

作者信息

Swaan P W, Koops B C, Moret E E, Tukker J J

机构信息

Department of Pharmaceutics, Utrecht Institute of Pharmaceutical Sciences, (UIPS), University of Utrecht, The Netherlands.

出版信息

Recept Channels. 1998;6(3):189-200.

PMID:10100327
Abstract

The present study was undertaken to examine the relationship between chemical structure (steric and electrostatic fields) and affinity for the small intestinal oligopeptide carrier (PepT1) using comparative molecular field analysis (CoMFA), a three-dimensional approach towards building quantitative structure-activity relationships. Various biological activity parameters (Kt, Jmax, Pc) and molecular descriptors (CoMFA fields, isobutylalcohol/water distribution coefficients) were examined. The resulting field map provides information on the geometry of the binding site cavity and the relative weights of various properties in different site pockets for each of the substrates considered. The results indicate that carrier permeability (Pc), calculated as the ratio of the half-maximal concentration (Kt) and the maximal carrier flux (Jmax), is sensitive to composition, size and hydrophobicity of the ligands. The best model obtained showed a high correlation between the carrier permeability (Pc) and the steric (76.3% contribution) and electrostatic (23.7% contribution) molecular fields with a cross-validated r2 (q2) of 0.754. The model fitted the experimental data with a correlation coefficient of 0.993 and a standard error of 0.041, while the regression line between experimental and calculated Pc had a slope of 0.994 with an intercept of 0.009. These results lead to a better understanding of the molecular requirements for optimal drug-carrier interactions with the intestinal peptide transporter and offers a useful visual aid for designing new potentially interesting structures with affinity for the oligopeptide transporter PepT1.

摘要

本研究旨在利用比较分子场分析(CoMFA)这一构建定量构效关系的三维方法,研究化学结构(空间和静电场)与小肠寡肽转运载体(PepT1)亲和力之间的关系。研究了各种生物活性参数(Kt、Jmax、Pc)和分子描述符(CoMFA场、异丁醇/水分配系数)。所得的场图提供了关于结合位点腔的几何形状以及所考虑的每种底物在不同位点口袋中各种性质的相对权重的信息。结果表明,以半数最大浓度(Kt)与最大载体通量(Jmax)之比计算的载体渗透率(Pc)对配体的组成、大小和疏水性敏感。所获得的最佳模型显示载体渗透率(Pc)与空间场(贡献76.3%)和静电场(贡献23.7%)之间具有高度相关性,交叉验证的r2(q2)为0.754。该模型与实验数据的拟合相关系数为0.993,标准误差为0.041,而实验和计算的Pc之间的回归线斜率为0.994,截距为0.009。这些结果有助于更好地理解药物与肠道肽转运体之间最佳相互作用的分子要求,并为设计对寡肽转运体PepT1具有亲和力的新的潜在有趣结构提供了有用的直观辅助工具。

相似文献

1
Mapping the binding site of the small intestinal peptide carrier (PepT1) using comparative molecular field analysis.利用比较分子力场分析绘制小肠肽转运体(PepT1)的结合位点图谱。
Recept Channels. 1998;6(3):189-200.
2
Three-dimensional quantitative structure-activity relationship analyses of peptide substrates of the mammalian H+/peptide cotransporter PEPT1.哺乳动物H⁺/肽共转运体PEPT1的肽底物的三维定量构效关系分析
J Med Chem. 2003 Dec 18;46(26):5725-34. doi: 10.1021/jm030976x.
3
Intestinal peptide transport: ex vivo uptake studies and localization of peptide carrier PEPT1.肠道肽转运:离体摄取研究及肽载体PEPT1的定位
Am J Physiol Gastrointest Liver Physiol. 2001 Sep;281(3):G697-704. doi: 10.1152/ajpgi.2001.281.3.G697.
4
Sequence, tissue distribution and developmental changes in rat intestinal oligopeptide transporter.大鼠肠道寡肽转运体的序列、组织分布及发育变化
Biochim Biophys Acta. 1996 Feb 7;1305(1-2):34-8. doi: 10.1016/0167-4781(95)00208-1.
5
The predominant contribution of oligopeptide transporter PepT1 to intestinal absorption of beta-lactam antibiotics in the rat small intestine.寡肽转运体PepT1对大鼠小肠中β-内酰胺类抗生素肠道吸收的主要贡献。
J Pharm Pharmacol. 1997 Aug;49(8):796-801. doi: 10.1111/j.2042-7158.1997.tb06115.x.
6
The intestinal H+/peptide symporter PEPT1: structure-affinity relationships.肠道H⁺/肽转运体PEPT1:结构-亲和力关系
Eur J Pharm Sci. 2004 Jan;21(1):53-60. doi: 10.1016/s0928-0987(03)00142-8.
7
Synthesis of analogs of L-valacyclovir and determination of their substrate activity for the oligopeptide transporter in Caco-2 cells.L-伐昔洛韦类似物的合成及其在Caco-2细胞中对寡肽转运体的底物活性测定。
Eur J Pharm Sci. 2002 Jul;16(1-2):1-13. doi: 10.1016/s0928-0987(02)00047-7.
8
Di/tri-peptide transporters as drug delivery targets: regulation of transport under physiological and patho-physiological conditions.二肽/三肽转运体作为药物递送靶点:生理和病理生理条件下转运的调控
Curr Drug Targets. 2003 Jul;4(5):373-88. doi: 10.2174/1389450033491028.
9
Molecular modeling of the intestinal bile acid carrier: a comparative molecular field analysis study.肠道胆汁酸载体的分子建模:一项比较分子力场分析研究。
J Comput Aided Mol Des. 1997 Nov;11(6):581-8. doi: 10.1023/a:1007919704457.
10
Stoichiometry and pH dependence of the rabbit proton-dependent oligopeptide transporter PepT1.兔质子依赖型寡肽转运体PepT1的化学计量学及pH依赖性
J Physiol. 1997 Feb 1;498 ( Pt 3)(Pt 3):563-9. doi: 10.1113/jphysiol.1997.sp021883.

引用本文的文献

1
A charge pair interaction between Arg282 in transmembrane segment 7 and Asp341 in transmembrane segment 8 of hPepT1.人肽转运体1(hPepT1)跨膜区段7中的精氨酸282与跨膜区段8中的天冬氨酸341之间的电荷对相互作用。
Pharm Res. 2007 Jan;24(1):66-72. doi: 10.1007/s11095-006-9119-x. Epub 2006 Sep 29.
2
Development of a QSAR model for binding of tripeptides and tripeptidomimetics to the human intestinal di-/tripeptide transporter hPEPT1.用于三肽及三肽模拟物与人肠道二肽/三肽转运蛋白hPEPT1结合的定量构效关系(QSAR)模型的开发。
Pharm Res. 2006 Mar;23(3):483-92. doi: 10.1007/s11095-006-9462-y. Epub 2006 Feb 26.
3
Membrane topology of human ASBT (SLC10A2) determined by dual label epitope insertion scanning mutagenesis. New evidence for seven transmembrane domains.
通过双标记表位插入扫描诱变确定人ASBT(SLC10A2)的膜拓扑结构。七跨膜结构域的新证据。
Biochemistry. 2006 Jan 24;45(3):943-53. doi: 10.1021/bi052202j.
4
In vitro and pharmacophore-based discovery of novel hPEPT1 inhibitors.基于体外实验和药效团的新型人肽转运体1(hPEPT1)抑制剂的发现
Pharm Res. 2005 Apr;22(4):512-7. doi: 10.1007/s11095-005-2505-y. Epub 2005 Apr 7.
5
Targeting the sodium-dependent multivitamin transporter (SMVT) for improving the oral absorption properties of a retro-inverso Tat nonapeptide.靶向钠依赖性多种维生素转运体(SMVT)以改善反向Tat九肽的口服吸收特性。
Pharm Res. 2001 Jul;18(7):950-6. doi: 10.1023/a:1010932126662.